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Abstract
The rapid rise in the prevalence of obesity and diabetes has significantly contributed to the
increasing global burden of noncommunicable diseases. Insulin resistance is a major
underpinning etiology of both obesity and type 2 diabetes. Insulin resistance is character-
ized by a reduced response of skeletal, liver, and fat tissues to the actions of insulin
hormone. Although detailed mechanisms implicated in the development of insulin resis-
tance remain plausible, skeletal muscles have been identified to play an integral role in the
improvement of insulin sensitivity in the diseased state. The effective modulation of
glucose and fatty acid metabolism in the skeletal muscle through exercise or by certain
therapeutics has been associated with reversal of insulin resistance and amelioration of
diabetes associated complications such as inflammation and oxidative stress. This chapter
will briefly discuss the role of glucose and fatty acid metabolism in the development of
insulin resistance in the skeletal muscle.
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1. Introduction
According to the World Health Organization, type 2 diabetes mellitus (T2D) contributes to
approximately 90% of all diabetes mellitus cases and is amongst the top 10 leading causes of
death worldwide [1]. Symptoms such as enhanced thirst, polyuria, fatigue, and impaired
wound healing are identified in those with T2D. The recent International Diabetes Federation
(IDF) report projects an astonishing increase in cases of diabetes [2]. An estimated 425 million
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people are currently living with diabetes, with a projected 1.5 fold increase in the prevalence of
diabetes, while a total of 629 million adults are expected to be diabetic by the year 2045 [2]. In
Africa, the prevalence of diabetes is estimated at 16 million and is expected to rise to 41 million
by 2045 [2]. Diabetes is characterized by hyperglycemia resulting from an inadequate produc-
tion of insulin and insulin utilization in a T2D state. An unhealthy lifestyle such as lack of
physical activity and a diet containing excessive fat content, including refined carbohydrates
has been associated with an increased risk for developing insulin resistance (IR) [2, 3].
Carbohydrate-rich diets with a high glycemic index may contribute to obesity, impaired
glucose tolerance, and hyperinsulinemia. This consequence can impair glucose and lipid
metabolism, and accelerate the progression of IR. During a state of IR, insulin levels are
elevated due to the rising glucose levels, but over time, a state of relative inadequate produc-
tion of insulin can develop [2]. IR is regarded as one of the early phenotypes associated with
development of obesity, and it is normally present in high-risk individual’s years before
development of T2D. Although maintenance of healthy lifestyle, as well as the use of
hypolipidemic and hypoglycemic drugs, remains effective at attenuating insulin-resistant
complications, the escalating incidence of the metabolic syndrome (MetS) warrants further
exploration into pathological mechanisms implicated in the development of IR. Accumulative
evidence suggests that effective modulation of energy substrates such as glucose and free fatty
acids (FFAs) remains crucial in the amelioration of lifestyle diseases, including T2D [4–6]. This
chapter will discuss the role of glucose and lipid metabolism in the development of IR.
2. Skeletal muscle and its role in modulating insulin resistance
Skeletal muscles are comprised of an intricate tissue, with diverse network of fibers, which
have different mechanical and metabolic functions. Skeletal muscles contribute to approxi-
mately 40% of the total body weight and contain 50–75% of all body proteins [7]. Skeletal
muscles account for more than 80% of insulin-stimulated glucose uptake [8], and using com-
bined oral and intravenous glucose tolerance testing, Himsworth and Kerr were able to dem-
onstrate that tissue-specific insulin sensitivity was lower in T2D individuals [9]. Therefore, IR
in skeletal muscle has a major impact on whole-body metabolic homeostasis and it is the main
element for the development of T2D. However, the underlying molecular mechanisms remain
elusive. Several mechanisms that play a role in the development of IR in skeletal muscle have
been proposed, and these include accumulation of intracellular lipid derivatives (diacylglycerol
and ceramides) as a result of elevated plasma FFAs, oxidative stress, pro-inflammatory signals,
and impaired gene transcription [8, 10]. Moreover, mitochondrial dysfunction has associated
with IR [11]. The following section will focus on glucose regulation and fatty acid metabolism, in
relation to the development of IR in skeletal muscle.
3. Glucose metabolism in skeletal muscle
Glucose is a monosaccharide used as a biological fuel during aerobic and anaerobic respiration
or fermentation. Aerobic respiration is the most efficient means of glucose utilization, yielding
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32 molecules of ATP during the processes of glycolysis and oxidative phosphorylation. Gly-
colysis is the metabolic whereby glucose is metabolized into pyruvate or to lactate; this process
yields higher capacity for ATP generation [12]. During glycolysis, glucose 6-phosphate is
converted to fructose-6-phosphate by phosphohexose, and then to fructose-1,6-biphosphate
by phosphofructokinase. This reaction is irreversible and is a major point of regulation during
glycolysis. Energy utilization by adult skeletal muscle is tightly controlled, with muscle fibers
having the ability to switch between different substrates for ATP production. This is highly
dependent on the availability of energy substrates and the energy requirements [13, 14].
Skeletal muscles are able to utilize both glucose and FFAs as a source of ATP production.
However, utilization of glucose and FFAs as a primary source of ATP production depends on
the metabolic state of an individual, i.e., whether the individual is at a fed or fasting state [15].
During the fasting state, glucose uptake in skeletal muscle is reduced while plasma FFA levels
are increased due to lipolysis in adipose tissue. This subsequently leads to the utilization of
FFAs as the predominant source of ATP production [16]; whereas, during a fed state, plasma
glucose levels are elevated, which stimulates insulin secretion and enhances glucose uptake by
skeletal muscle. This also leads to reduced lipolysis in adipose tissue and a reduction in plasma
FFAs. The ability of switching between substrates in the fasted and fed state is crucial in
promoting skeletal muscle glucose oxidation. Consequently, it has been reported that muscle
of insulin-resistant or diabetic subjects fails to switch between the substrates, showing meta-
bolic inflexibility [8]. This metabolic inflexibility can result in impaired glucose and fatty acid
metabolism, leading to the development of IR.
Several mechanisms, which include glucose transportation, are implicated in the regulation of
skeletal muscle glucose metabolism and have been a therapeutic target for the reversal IR and
improvement of skeletal muscle function. Briefly, postprandial glucose is transported actively
across the plasma membrane by specific carrier proteins, which belong to the glucose trans-
porter (GLUT) family. There are several types of glucose transporters located in the plasma
membrane of myocytes. Each glucose transporter isoform plays a specific role in glucose
transportation that is determined by its tissue distribution, substrate specificity, and transport
kinetics [17]. Glucose transporter isoform 1 (GLUT1) is present in all cells and is largely
responsible for regulating basal glucose and ensuring a steady influx of glucose into cells. The
glucose transporter isoform 2 (GLUT2) is a high-Km glucose transporter expressed in hepato-
cytes, pancreatic beta cells, and the basolateral membranes of intestinal and renal epithelial
cells. In contrast to other transporters, GLUT2 facilitates bidirectional glucose transport into
and out of the cell [17]. GLUT3 is a low-capacity glucose transporter that is responsible for
glucose uptake in neurons, while glucose transporter protein isoform 4 (GLUT4) is expressed
exclusively in muscle and fat cells, and is responsible for increased glucose uptake into these
tissues postprandially, thereby maintaining normoglycemia [17].
In skeletal muscle, insulin stimulation induces translocation of GLUT4 from intracellular vesi-
cles within the cytoplasm to the plasma membrane and thereby increases glucose uptake
[18, 19]. When insulin levels decrease in the blood and insulin receptors are no longer occupied,
the glucose transporters are recycled back into the cytoplasm. Failure of GLUT4 to translocate
to the plasma membrane results in IR [20]. The crucial step for effective modulation of GLUT4
translocation has been the binding of insulin or insulin-like growth factor 1 (IGF1) to its
receptor or IGF1 receptor, leading to the activation of phosphatidylinositol-4,5-bisphosphate
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3-kinase (PI3K)/protein kinase B (AKT) pathway. Activation of this pathway has been subject to
ongoing research for its role in skeletal muscle tissue growth, and most importantly, in the
regulation of insulin signaling [21]. This has been verified on various models showing that
knockout of insulin receptor, PI3K and AKT genes, especially in skeletal muscle, is associated
with growth retardation as well as with impairment of insulin action [22, 23]. Therefore,
effective modulation of glucose transportation and activation of PI3K/AKT pathway remains
important to improve glucose tolerance and also skeletal muscle function.
4. Fatty acid metabolism in skeletal muscle
FFAs are elongated hydrocarbon chains with a terminal carboxylate group. Apart from being
one of the major sources of fuel in the body, FFAs can perform a number of other functions,
including serving as building blocks for phospholipids and also acting as hormones as well as
intracellular messengers [24]. FFAs can exist in unsaturated or saturated form, depending on
the number of bonds the hydrocarbon chain contains. While unsaturated fats such as oleic
acid, mostly available in vegetable oils, are considered beneficial to the body [25], saturated
fats, namely palmitic acid, are associated with the development of IR [26]. For the latter, it is
widely used in experimental models to induce IR [19, 27]. Exposure of cultured skeletal muscle
cells to high palmitate concentrations has been linked with the activation of protein kinase C
(PKC), one of the main enzymes involved in impaired insulin signaling [26, 28]. Briefly, by
phosphorylating insulin receptor substrate 1, PKC can alter the whole downstream effect of
insulin response, ultimately leading to impaired GLUT4 translocation and reduced glucose
uptake in skeletal muscle. Evidence shows that PKC activation by 12-deoxyphorbol 13-
phenylacetate 20-acetate is associated with a reduction in insulin-stimulated glucose uptake,
whereas PKC inhibition with GF 109203X results in enhanced insulin action in cultured human
skeletal muscle [29]. An abnormal reduction of glucose uptake in skeletal muscle, mainly due
to an impaired switch in substrate preference, as explained by Randle [6], remains an impor-
tant contributing factor to the development of IR and subsequent metabolic complications.
Thus, it is a viable option to target glucose uptake improvement, concomitant to reducing
glycogen stores to reverse IR in skeletal muscle.
Beta oxidation, the main catabolic process by which fats are broken down in the body, is
another system crucial for the control of substrate switch within many cells, including skeletal
muscle (Figure 1). Generally, during periods of fasting, a substrate switch occurs where FFAs
become a predominant source for ATP production via beta oxidation [30]. Although FFAs are
hydrophobic in nature and can passively diffuse across the lipophilic cell membrane, trans-
porters such as plasma membrane fatty acid-binding protein (FABP), fatty acid transport
protein 1 (FATP1), and cluster of differentiation 36 (CD36) are widely expressed in rodent
and human skeletal muscle [31, 32]. By controlling entry of long chain fatty acids across the
barrier of the inner mitochondrial membrane for subsequent beta oxidation, the carnitine
shuttle system can influence skeletal muscle substrate switch. Some of the well-investigated
components of the system include the malonyl-CoA sensitive carnitine palmitoyltransferase 1
(CPT1) that resides on the mitochondrial outer membrane (Figure 1).
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Some polyphenols, including those from grape extracts, can influence muscle lipid metabolism
by reducing CD36 and regulating CPT1 expression in high fat diet (HFD) fed rats, leading to
upregulated GLUT4 protein expression and improved insulin signaling [33]. Similarly, metfor-
min, a commonly used antidiabetic drug, has demonstrated increased capacity to reverse IR
and improve skeletal muscle function through the modulation of CPT1 and 50 AMP-activated
protein kinase (AMPK) [34, 35]. Like PI3K/AKT, AMPK is also a target of ongoing research for
its role in preventing metabolic disease through modulation of substrate metabolism in vari-
ous tissues [36, 37]. Intracellular energy fluctuations, represented by changing AMP/ATP ratio,
such as those identified in an IR state, remain monumental for the activation or deactivation of
AMPK activity [38]. A number of natural products [39–41], including metformin, are known to
activate AMPK, leading to the phosphorylation of acetyl-CoA carboxylase and to effective
modulation of beta oxidation. However, the activity of AMPK is tissue specific and is tightly
controlled in a T2D state, with its activation demonstrated to be important in reversing IR and
improving signaling in skeletal muscle [19, 36].
5. Conclusions
Skeletal muscle forms the largest insulin-sensitive tissue in the body and remains the key site
for insulin-stimulated glucose uptake. Glucose and FFAs are the prominent substrates
Figure 1. Glucose and free fatty acids (FFAs) are the predominant substrates that are oxidized to generate acetyl-CoA,
which is then utilized by the electron transport chain to generate adenosine triphosphate (ATP). An insulin-resistant state
is characterized by an impaired substrate utilization, a process termed metabolic inflexibility. Modulation of phosphati-
dylinositol-4,5-bisphosphate 3-kinase/protein kinase B (PI3K/AKT) and 50 AMP-activated protein kinase (AMPK) signal-
ing mechanisms are increasingly targeted by various pharmacological compounds to reverse insulin resistance and
improve skeletal muscle function. Abbreviations: CD36: cluster of differentiation 36, CPT1: carnitine palmitoyltransferase
1, DAG: diacyl glycerol, FAO: fatty acid oxidation, FATP: fatty acid transport protein 1, GLUT4: glucose transporter
isoform 4, GO: glucose oxidation, IR: insulin receptor, and PKC: protein kinase C.
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responsible for ATP production in the skeletal muscle. However, in an insulin-resistant state, the
utilization of both glucose and FFAs is impaired, leading to abnormally enhanced intramuscular
substrate storage. Modulation of the PI3K/AKT and AMPK signaling appears to be the driving
mechanism responsible for the regulation of substrate metabolism, as well as associated down-
stream effects such as generation of oxidative stress. Interestingly, some pharmacological
compounds such as metformin are known to exert their therapeutic effects through the modu-
lation of these pathways, leading to improved control of energy substrates. Therefore, it is
imperative that more research be directed at exploring signaling mechanisms implicated in the
control of energy substrates, especially in the skeletal muscle, since it is known to be the major
“hub” for energy metabolism.
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